about
Models and methods for in vitro testing of hepatic gap junctional communicationMevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cellsThe possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical studyHistone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cellsEpigenetic regulation of inflammatory cytokines and associated genes in human malignanciesProtein degradation pathways regulate the functions of helicases in the DNA damage response and maintenance of genomic stabilityThe histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysAcetylation of p53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway.Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of SnailDiscovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells.Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.Histone-mediated epigenetics in addiction.Cylindromatosis--A Protective Molecule against Liver Diseases.Histone deacetylase inhibition prevents cell death induced by loss of tricellular tight junction proteins in temperature-sensitive mouse cochlear cells.Histone Deacetylase Inhibitors as Anticancer Drugs.Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages.Induction of cell differentiation activates transcription of the Sarco/Endoplasmic Reticulum calcium-ATPase 3 gene (ATP2A3) in gastric and colon cancer cells.Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death.Histone deacetylases function as a novel potential therapeutic target for cancer.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer.Diversity-oriented synthesis of analogues of the novel macrocyclic peptide FR-225497 through late stage functionalization.Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer CellsThe transcriptional response of skin to fluorescent light exposure in viviparous (Xiphophorus) and oviparous (Danio, Oryzias) fishes.Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on In Vitro Models for Plant-Derived Compounds.Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53.Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue.Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death.Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1.Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization.
P2860
Q26784350-B4C8ACA9-D6B4-4D3D-836F-8BCCE6114141Q33566705-33FC4FE3-CB7F-49F1-8E05-EC03917531E0Q33712267-44053864-6FEC-47CF-AA94-99F450625503Q33808800-79BA510E-DD75-4BCA-A5A9-918B3183563CQ35178132-B7B9908C-782E-49FA-B4BD-5696C7099A88Q35833998-E9A27AA1-5EB4-4D59-8518-226C7585FC87Q36157305-6C59F748-5DB9-4C9F-B85C-FF0EDD5972D7Q36755004-791834D8-6CD4-4BA4-8FAB-F9C568B3FD79Q37114711-2844940C-6EBD-485F-8897-9E9A0FDA4C88Q37269205-CC80771B-F14A-4775-A743-735553FDABA9Q37368670-EBBD3C0C-ADDC-4FEE-8C59-727FC1795D60Q37399295-109C9262-A289-496C-A811-A38C0FA75D18Q37591018-014CA015-8DF8-4A0D-998A-FBF119B53E40Q38269737-6E974C1D-6C28-435E-9A15-61D107A6C290Q38695458-DCBAB867-045A-43A1-8E5C-C5881AA5CD34Q38695885-E0F9F4D5-3AC9-45A5-B1AE-4C74B5C85066Q38696932-3A7F1452-B3A5-4740-94F9-C4248D737057Q38731925-90084593-78D8-4856-A2CD-B2B1FC87F68AQ38741165-5B060008-D7F9-456F-B8EE-127C8A116988Q38741197-D513B359-F679-4989-BD1D-79A386C3828DQ38756996-BA3E9AC8-246A-4D64-A164-BFF874A4651EQ38788965-0C89497D-1DB3-4B2C-8D71-00F35D16F813Q38796545-718889F6-0A44-48E8-8FCE-724E159132EEQ38869610-98F6D76C-4BA3-4C41-9459-FBE94DDD3095Q38908331-1A6041F5-848E-43A3-A78F-E7A5E88EE348Q38947405-981E1435-82B8-4ECE-AE31-BE9CA52CB7D2Q39496138-50F22510-20AE-43A4-8188-385145130068Q41382946-00EEF027-FDCA-4520-8630-B0D912DDA10DQ42137756-A3476B56-F24E-4C6B-A0B5-BF630C493CADQ42328146-468CCC5C-7485-41FF-9A17-34E8E8EED2DBQ42778078-127E7DA9-C37F-4FFC-B519-A407EF986DFCQ46248252-83DD0A15-8963-475E-8DEB-F812F211DF0CQ46341905-1086B550-DAF8-4C37-B4F0-3D70350B82A0Q47136872-F4063987-F962-4144-AB0C-EF8E06C6C7EAQ47154262-F0DAEFA1-1C62-48B8-89E6-FD264E0FE42DQ47645910-22511DED-FD43-4551-BEE2-8AFF939413FEQ49375826-E57D2782-3AD0-408A-8650-7EBBBC3D54B1Q50091965-1CB789AB-4C3A-447E-B98F-4FB739B9F58FQ51176745-15D42180-0CDE-4DEA-9E3F-1911005A42A8Q51374049-94969458-1598-490E-9BDA-A176CF997604
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Histone deacetylase inhibitors and cell death.
@en
type
label
Histone deacetylase inhibitors and cell death.
@en
prefLabel
Histone deacetylase inhibitors and cell death.
@en
P2860
P1476
Histone deacetylase inhibitors and cell death.
@en
P2093
Jing Zhang
Qing Zhong
P2860
P2888
P304
P356
10.1007/S00018-014-1656-6
P577
2014-06-05T00:00:00Z